News

Itonis has pre-paid necessary funds to Oasis to commence the inaugural production run. "The Company is excited that we have finally developed Emesyl to start production. We are

TrialOne is a browser-based bedside data collection technology designed specifically to address the needs of Phase I clinics. Subject recruitment, study data capture, sample tracking, reporting, data management

The research grant will be used to study the administration of a transmucosal Lorazepam Spray for the treatment of epileptic seizures in the outpatient settings. EastGate explores drug

Xiapex is the trade name for collagenase clostridium histolyticum (CCH) in the European Union (EU). Currently, Xiapex is approved to treat Dupuytren’s contracture in adult patients with a

The double-masked, randomized sham controlled trial is designed to evaluate the safety, tolerability and pharmacokinetics of QPI-1007 in these patients. QPI-1007 is a siRNA designed drug designed to

ADXS-cHER2 is being developed to target the Her2 receptor, which is overexpressed in certain solid-tumor cancers, including bone cancer (osteosarcoma), breast cancer, esophageal and gastric cancer. The company

Mersana’s Fleximer technology will be used in the development of ADCs for multiple undisclosed targets. The two firms will test a variety of ADCs by using Mersana’s platform

The purchase price of Dava is $575m in cash, with additional consideration of about $25m contingent on the achievement of certain sales milestones. The acquisition would improve Endo’s

The company said that the patent has broad coverage and protects development of any apoptosis-inducing ICAM-1 antibody. BioInvent chief scientific officer Björn Frendéus said the company is happy